Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals
- PMID: 1178902
- DOI: 10.1016/0090-6980(75)90040-4
Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals
Abstract
The influence of methyl esterification of the carboxyl group of PGE1 on the gastric antisecretory and antiulcer activities were studied. The gastric antisecretory effects of PGE1 free acid and PGE1 methyl ester (PGE1ME) were studied in the Heidenhain pouch dog. Secretion was stimulated with constant intravenous infusion of histamine dihydrochloride. When a steady-state plateau of gastric secretion had been reached, the prostaglandins were administered either by a single intravenous bolus (10.0 mug/kg) or by continuous infusion (1.0 mug/kg/min). PGE1ME was found to be slightly more potent and longer-acting than PFE1 when administered by a single i.v. bolus. PGE1ME was also shown to be more potent than PGE1 when infused intravenously for a two-hour period. PGE1ME caused a significant alteration in gastric juice concentration of hydrogen and sodium ions in an inverse relationship. Potassium and chloride concentration were not altered from pre-existing steady-state values following administration of either form of prostaglandin. Similarly, PGE1ME was also found to possess significantly greater antiulcer activity in the rat forced-exertion ulcer test. These findings support the hypothesis that methyl esterification of the prostaglandin molecule will increase some of the biological actions of PGE1 through inhibition of metabolic beta-oxidation of the carboxylic side chain.
Similar articles
-
Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs.Prostaglandins. 1975 Nov;10(5):733-45. doi: 10.1016/0090-6980(75)90002-7. Prostaglandins. 1975. PMID: 1215536
-
SC-29333: a potent inhibitor of canin gastric secretion.Am J Dig Dis. 1976 Dec;21(12):1049-57. doi: 10.1007/BF01071862. Am J Dig Dis. 1976. PMID: 797257
-
Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys.Prostaglandins. 1976 May;11(5):799-808. doi: 10.1016/0090-6980(76)90188-x. Prostaglandins. 1976. PMID: 819967
-
Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.Gastroenterology. 1976 Mar;70(3):359-70. Gastroenterology. 1976. PMID: 174967 Review.
-
[The state of the art of gastric antisecretory drugs].Nihon Yakurigaku Zasshi. 1993 Sep;102(3):235-44. doi: 10.1254/fpj.102.235. Nihon Yakurigaku Zasshi. 1993. PMID: 8406234 Review. Japanese.
Cited by
-
Gastric antisecretory effects of E prostaglandins in Rhesus monkeys.Am J Dig Dis. 1976 Dec;21(12):1020-8. doi: 10.1007/BF01071857. Am J Dig Dis. 1976. PMID: 827937
-
Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.Dig Dis Sci. 1991 May;36(5):588-93. doi: 10.1007/BF01297024. Dig Dis Sci. 1991. PMID: 1850690
-
Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.Dig Dis Sci. 1987 Sep;32(9):1010-6. doi: 10.1007/BF01297192. Dig Dis Sci. 1987. PMID: 3040357
-
Exogenous prostaglandins and gastric secretion in the cat.J Physiol. 1978 May;278:441-50. doi: 10.1113/jphysiol.1978.sp012315. J Physiol. 1978. PMID: 353255 Free PMC article.
-
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.Drugs. 1987 Jan;33(1):1-30. doi: 10.2165/00003495-198733010-00001. Drugs. 1987. PMID: 3102205 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources